From the GPEI weekly report on the current situation in Papua province: ‘In total, three genetically-linked circulating vaccine-derived poliovirus type 1 (cVDPV1) isolates were detected from Papua province. In addition to the above-listed isolate, cVDPV1 was isolated from an acute flaccid paralysis (AFP) case, with onset of paralysis on 27 November 2018, and from a sample of a healthy community contact, collected on 24 January 2019. This outbreak is not linked to the cVDPV1 currently affecting neighbouring Papua New Guinea.’ Investigations into the occurrence and the necessary response measures are continuing. In the same report, more on Nigeria’s situation: ‘One case of circulating vaccine-derived poliovirus type 2 has been reported this week in Kaiama LGA, Kwara State. This is third case in Kwara State and the second in 2019 in Nigeria.’
Advice for travellers
Polio is a potentially serious viral illness that is spread through contact with infected faeces or saliva. The risk to travellers is generally low, however vaccination is recommended for travel to affected regions and is a requirement for travel to/from some countries. If at risk, adults should have a booster to the childhood series. More on polio.
Before you travel, call Travelvax Australia’s telephone advisory service on 1300 360 164 (toll-free from landlines) for country-specific advice and information. You can also make an appointment at your nearest Travelvax clinic to obtain vaccinations, medication to prevent or treat illness, and accessories for your journey.